Global Game
-
-
Vertex Pharmaceuticals: The price of inspiration
Vertex Pharmaceuticals' new $200,000-a-year cystic fibrosis drug could help 90 percent of patients breathe. It's an amazing—and profitable—innovation. But will that windfall spur the 28-year-old startup to do it again?
-
Velodyne: Eyes on the road
How Velodyne's vision sensors are ushering in the self-driving-car revolution
-
GreenSky's David Zalik: The middleman of middle America
David Zalik never graduated from high school, much less college. But the numbers whiz could do the math: Making money from both sides of a home-renovation loan, without the risk of defaults, can make you a billionaire
-
Peugeot on the go
After resurrecting the French carmaker Groupe PSA, Carlos Tavares is taking on the global giants by gambling on bleeding-edge manufacturing techniques and selling services that support other companies' cars
-
Tom Siebel's second act
A decade after Tom Siebel sold his first company to Oracle for $5.9 billion, his new company could be twice as valuable
-
Utah: Cloud's new capital
Led by three unicorns eyeing an IPO, Utah is becoming as well-known for its cloud as for its mountains
-
Choo Chong Ngen goes beyond 'love hotels'
The Singapore-based hotelier expands beyond the familiar Hotel 81 to woo a different budget customer to his brand of inns
-
Serial Pleasure: China's online reading craze is challenging Kindle
Chinese e-books provide an interactive reading experience, where readers and writers can discuss and co-develop the plot
-
Aier Eye Hospital: Eyeing new markets
Why China's largest ophthalmological hospital chain is focusing on the US
-
How Indian education companies tanked due to unsustainable business models
Asset-heavy Indian schooling firms sink after good early marks